Ligand Pharmaceuticals Incorporated

(NASDAQ:LGND)

Latest On Ligand Pharmaceuticals Incorporated (LGND):

Date/Time Type Description Signal Details
2023-05-05 02:41 ESTNewsLigand Pharmaceuticals Non-GAAP EPS of $2.28 beats by $1.39, revenue of $43.9M beats by $10.35MN/A
2023-05-05 02:41 ESTNewsLigand Pharma up 5% after hours on 2023 guidance boostsN/A
2023-05-05 02:40 ESTNewsLigand Pharmaceuticals Incorporated (LGND) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 01:22 ESTNewsLigand Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-03-25 18:50 ESTNewsLigand Pharmaceuticals: Expanding Royalty Portfolio And Strong Drug PipelineN/A
2023-02-23 03:25 ESTNewsLigand Pharmaceuticals Non-GAAP EPS of $1.36 beats by $0.24, revenue of $50.38M beats by $10.75MN/A
2023-02-23 03:25 ESTNewsLigand Pharmaceuticals, Inc. (LGND) Q4 2022 Earnings Call TranscriptN/A
2023-02-22 01:57 ESTNewsLigand Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-02-13 21:55 ESTNewsOmniAb initiated with a buy at H.C. Wainwright on antibody collaborations, partnershipsN/A
2023-01-06 13:42 ESTNewsNovan submits NDA for berdazimer gel for viral skin infectionN/A
2022-12-30 10:49 ESTNewsA New Ligand Is Taking ShapeN/A
2022-12-05 10:32 ESTNewsLigand Pharmaceuticals names new CEON/A
2022-11-08 14:51 ESTNewsLigand Pharmaceuticals, Inc. (LGND) Q3 2022 - Earnings Call TranscriptN/A
2022-11-08 14:50 ESTNewsLigand rises 16% as company sees 2022 earnings above estimatesN/A
2022-11-07 21:02 ESTNewsLigand Pharmaceuticals Non-GAAP EPS of $0.41 misses by $0.02, revenue of $66.09M beats by $27.76MN/A
2022-11-07 04:50 ESTNewsLigand Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-11-02 19:30 ESTNewsLigand Pharma jumps 32% as OmniAb completes spinoff and mergerN/A
2022-10-26 03:29 ESTNewsSPAC APAC shareholders approve merger with Ligand spinoff OmniAbN/A
2022-09-25 12:04 ESTNewsLigand Pharmaceuticals: Struggling AlongN/A
2022-09-13 13:35 ESTNewsLigand, Sermonix breast cancer drug lasofoxifene fails to show 'statistical significance' in trialN/A
2022-08-09 04:31 ESTNewsLigand Pharmaceuticals Non-GAAP EPS of $1.03 beats by $0.60, revenue of $57.4M beats by $19.67MN/A
2022-08-09 04:31 ESTNewsLigand Pharmaceuticals, Inc. (LGND) CEO John Higgins on Q2 2022 Results - Earnings Call TranscriptN/A
2022-05-05 05:30 ESTNewsLigand Pharmaceuticals Non-GAAP EPS of $0.76 beats by $0.10, revenue of $45.69M beats by $11.48MN/A
2022-05-05 05:30 ESTNewsLigand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 08:41 ESTNewsLigand Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-03-29 03:41 ESTNewsLigand Pharmaceuticals: Moving Parts Keep MovingN/A
2022-02-18 16:58 ESTNewsLigand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-17 19:41 ESTNewsLigand Pharmaceuticals Non-GAAP EPS of $1.80 beats by $0.43, revenue of $72.5M beats by $7.41MN/A
2022-02-16 23:33 ESTNewsLigand Pharmaceuticals Q4 2021 Earnings PreviewN/A
2021-12-31 07:47 ESTNewsLigand: Green Shoots And A Hidden Treasure - A Spinoff Bonus For The New YearN/A
2021-12-21 23:48 ESTNewsLigand Pharma, GSK expand existing license dealN/A
2021-12-06 17:59 ESTNewsNDA for J&J's cilta-cel for multiple myeloma submitted to Japanese regulatorsN/A
2021-11-10 11:00 ESTNewsLigand Pharmaceuticals EPS beats by $0.54, beats on revenueN/A
2021-11-10 11:00 ESTNewsLigand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 10:59 ESTNewsBenchmark keeps buy rating on Ligand following Q3 2021 earnings beat; shares up 7%N/A
2021-11-09 11:56 ESTNewsLigand Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-10-22 14:43 ESTNewsLigand Pharmaceuticals and China Resources Double-Crane ink collaboration agreementN/A
2021-10-11 13:38 ESTNewsLigand's Ailing Remdesivir Cash CowN/A
2021-08-31 10:14 ESTNewsLigand Pharma announces approval of zimberelimab in China for Hodgkin’s lymphomaN/A
2021-08-31 10:14 ESTNewsPFGC, APPS rise on S&P's latest index shufflesN/A
2021-08-16 20:27 ESTNewsTravere meets primary efficacy endpoint in late-stage trial for IgA nephropathy (updated)N/A
2021-07-30 16:42 ESTNewsLigand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-29 21:14 ESTNewsLigand Pharmaceuticals EPS beats by $0.27, beats on revenue; updates full year guidanceN/A
2021-07-29 00:39 ESTNewsLigand Pharmaceuticals Q2 2021 Earnings PreviewN/A
2021-07-21 14:16 ESTNewsFDA grants J&J multiple myeloma treatment cilta-cel priority reviewN/A
2021-07-21 13:45 ESTNewsLigand Pharmaceuticals adds Jennifer Cochran to its board of directorsN/A
2021-07-21 13:43 ESTNewsLigand: 2021 Is PivotalN/A
2021-07-21 13:38 ESTNewsJazz Pharmaceuticals launches leukemia/lymphoma treatment RylazeN/A
2021-05-04 01:21 ESTNewsLigand Pharmaceuticals EPS beats by $0.28, misses on revenueN/A
2021-05-04 01:21 ESTNewsLigand swings to Q1 profit, but shares fall more than 6% after hoursN/A

About Ligand Pharmaceuticals Incorporated (LGND):

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. The company's commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for the treatment of osteoporosis; Nexterone, a captisol-enabled formulation of amiodarone; Zulresso, a captisol-enabled formulation of brexanolone for the treatment of PPD; Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of postmenopausal osteoporosis; Aziyo portfolio of commercial pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune diseases; Vivitra for breast cancer; Bryxta and Zybev for various indications; and Minnebro for the treatment of hypertension. The company's partners programs, which are in clinical development used for the treatment of cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney, and other diseases. In addition, the company is involved in the sale of Captisol materials. Ligand Pharmaceuticals Incorporated was founded in 1987 and is headquartered in San Diego, California.

LGND Quotes by TradingView

See Advanced Chart

General

  • Name Ligand Pharmaceuticals Incorporated
  • Symbol LGND
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 155
  • Last Split Factor1:6
  • Last Split Date2010-11-19
  • Fiscal Year EndDecember
  • IPO Date1992-11-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ligand.com
View More

Valuation

  • Trailing PE 4161
  • Forward PE 28.99
  • Price/Sales (Trailing 12 Mt.) 14.41
  • Price/Book (Most Recent Quarter) 3.89
  • Enterprise Value Revenue 15.03
  • Enterprise Value EBITDA 62.49
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $6.17
  • Next Year EPS Estimate $4.86
  • Next Quarter EPS Estimate $1.10
  • Profit Margin -2%
  • Operating Margin 16%
  • Return on Assets 1%
  • Revenue 186.42 million
  • Earnings Per Share $28.29
  • Revenue Per Share $11.52
  • Gross Profit 96.61 million
  • Quarterly Earnings Growth 159.2%
View More

Highlights

  • Market Capitalization 2.57 billion
  • EBITDA 57.4 million
  • PE Ratio 24.62
  • PEG Ratio 1.93
  • Analyst Target Price $224.67
  • Book Value Per Share $44.13
View More

Share Statistics

  • Shares Outstanding 16.61 million
  • Shares Float 15.81 million
  • % Held by Insiders 421%
  • % Held by Institutions 146.13%
  • Shares Short 2.21 million
  • Shares Short Prior Month 2.74 million
  • Short Ratio 2.03
  • Short % of Float 22%
  • Short % of Shares Outstanding 13%
View More

Technicals

  • Beta 1.24
  • 52 Week High $219.75
  • 52 Week Low $66.06
  • 50 Day Moving Average 164.68
  • 200 Day Moving Average 114.57
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date 2010-07-02
  • Dividend Yield 0%
View More

Ligand Pharmaceuticals Incorporated (LGND) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ligand Pharmaceuticals Incorporated (LGND) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-03$69.99 million$0.35$0.40-11.39%
2020-09-302020-10-30$N/A-$0.42$0.53-179.62%
2020-06-302020-08-03$N/A$1.32$0.7673.68%
2020-03-312020-05-06$N/A-$1.46$0.12-1351.07%
2019-12-312020-02-06$27 million-$0.43-$0.27-59.26%
2019-09-302019-11-05$24.81 million-$0.81$0.41-297.56%
2019-06-302019-07-30$24.99 million-$0.74$0.66-212.98%
2019-03-312019-05-02$43.48 million$31.32$28.868.54%
2018-12-312019-02-07$59.59 million-$2.02$0.90-323.45%
2018-09-302018-11-08$45.66 million$2.80$0.47490.72%
2018-06-302018-08-06$90.04 million$2.99$2.1141.71%
2018-03-312018-05-08$56.16 million$1.83$0.63191.4%
2017-12-312018-02-21$50.46 million-$0.33$0.73-145.21%
2017-09-302017-11-09$33.38 million$0.36$0.38-4%
2017-06-302017-08-07$28 million$0.26$0.10151.69%
2017-03-312017-05-09$29.27 million$0.22$0.32-31.78%
2016-12-312017-02-23$38.19 million-$0.15$0.69-121.68%
2016-09-302016-11-03$21.62 million$0.03$0.11-71.7%
2016-06-302016-08-04$19.52 million-$0.28$0.05-618.52%
2016-03-312016-05-04$29.65 million$0.30$0.38-20%
2015-12-312016-02-10$21.19 million$0.29$0.36-20%
2015-09-302015-11-09$17.7 million$0.56$0.4233.33%
2015-06-302015-08-04$18.42 million$1.81$0.40352.5%
2015-03-312015-05-11$14.6 million$0.33$0.2722.22%
2014-12-312015-02-09$23 million$0.60$0.600%
2014-09-302014-10-27$14.97 million$0.36$0.3116.13%
2014-06-302014-08-04$10.61 million$0.24$0.1471.43%
2014-03-312014-05-07$15.96 million$0.35$0.2540%
2013-12-312014-02-11$14.74 million$0.28$0.1947.37%
2013-09-302013-10-30$13.01 million$0.12$0.0771.43%
2013-06-302013-08-01$9.58 million$0.07$0.0540%
2013-03-312013-05-08$11.65 million$0.16$0.0977.78%
2012-12-312013-02-13$13.64 million$0.19$0.21-9.52%
2012-09-302012-11-05$6.38 million-$0.01-$0.0475%
2012-06-302012-08-08$5.74 million-$0.20-$0.02-900%
2012-03-312012-05-02$5.64 million-$0.03-$0.02-50%
2011-12-312012-02-07$12.94 million$0.24$0.07242.86%
2011-09-302011-11-08$5.74 million-$0.09$0.01-1000%
2011-06-302011-08-08$7.46 million-$0.05$0.11-145.45%
2011-03-312011-05-10$3.9 million$0.48$0.05860%
2010-12-312011-02-15$3.94 million$0.12-$0.03500%
2010-09-302010-11-09$7.8 million-$3.60-$0.03-11900%
2010-06-302010-08-05$5.84 million-$0.01-$0.0350.67%
2010-03-312010-05-05$5.96 million-$0.12-$0.1833.33%
2009-12-312010-02-09$13.97 million$0.06-$0.12150%
2009-09-302009-11-05$7.9 million$0.06-$0.24125%
2009-06-302009-08-03$7.59 million-$0.30-$0.4126.83%
2009-03-312009-05-06$9.47 million-$0.30-$0.27-11.11%
2008-12-312009-02-12$12.39 million-$4.56-$0.39-1069.23%
2008-09-302008-11-06$5.25 million-$0.60-$0.30-100%
2008-06-302008-07-31$4.8 million-$0.30-$0.4228.57%
2008-03-312008-05-01$4.87 million-$0.60-$0.27-122.22%
2007-12-312008-02-20$5.77 million$0.36-$0.09500%
2007-09-302007-11-08$5.48 million$0.06-$0.12150%
2007-06-302007-08-08$1.41 million$0.01-$0.30103.63%
2007-03-312007-05-10$235000$16.32$16.68-2.16%
2006-12-312007-03-15$140.96 million$8.52$10.14-15.98%
2006-09-302006-11-14$-1063000-$1.26-$0.66-90.91%
2006-06-302006-08-09$1.06 million-$0.96-$0.54-77.78%
2006-03-312006-05-15$2.91 million-$11.01
2005-12-312006-03-16$35.7 million-$0.24-$0.5455.56%
2005-09-302005-11-18$32 million-$1.44-$0.85-69.41%
2005-06-302005-08-09$18.32 million-$0.72
2005-03-312005-05-15$36.99 million-$1.50
2004-12-312005-02-15$67.05 million$1.02$2.55-60%
2004-09-302004-11-09$36.77 million-$0.54-$0.06-800%
2004-06-302004-08-03$32.27 million-$1.14-$0.36-216.67%
2004-03-312004-05-05$27.42 million-$1.08-$0.35-208.57%
2003-12-312004-03-03$57.61 million$0.60$0.17252.94%
2003-09-302003-10-31$31.28 million-$0.96-$0.56-71.43%
2003-06-302003-07-28$29.13 million-$1.02-$0.83-22.89%
2003-03-312003-04-24$23.12 million-$1.32-$0.69-91.3%
2002-12-312003-02-25$27.32 million-$0.54$0.02-2800%
2002-09-302002-11-12$25.27 million-$0.60-$0.06-900%
2002-06-302002-08-13$19.17 million-$1.02-$0.54-88.89%
2002-03-312002-05-03$24.89 million-$0.42-$0.06-600%
2001-12-312002-03-11$22.64 million-$0.54-$0.7022.86%
2001-09-302001-10-26$19.17 million-$0.78-$0.847.14%
2001-06-302001-08-01$17.49 million-$1.08-$1.2010%
2001-03-312001-04-30$17.04 million-$1.20-$1.14-5.26%
2000-12-312000-12-31$13.83 million-$1.34
2000-09-302000-09-30$13.59 million-$1.58
2000-06-302000-06-30$9.87 million-$1.78
2000-03-312000-03-31$10.82 million-$1.67
1999-12-312000-03-10-$2.88-$1.35-113.33%
1999-09-301999-11-15-$2.34-$1.86-25.81%
1999-06-301999-08-16-$2.40-$0.78-207.69%
1999-03-311999-05-13-$1.92-$1.80-6.67%
1998-12-311999-03-30-$3.54-$1.22-190.16%
1998-09-301998-11-18-$2.40-$1.23-95.12%
1998-06-301998-08-14-$2.70-$2.25-20%
1998-03-311998-05-18-$2.10-$2.162.78%
1997-12-311998-02-05-$0.54-$1.1151.35%
1997-09-301997-11-13-$2.10-$1.80-16.67%
1997-06-301997-08-14-$1.92-$1.86-3.23%
1997-03-311997-05-14-$1.92-$1.77-8.47%
1996-12-311997-03-31-$2.28-$1.88-21.28%
1996-09-301996-11-08-$1.80-$1.77-1.69%
1996-06-301996-08-14-$2.16-$1.65-30.91%
1996-03-311996-05-08-$1.50-$1.595.66%
1995-12-311996-03-28-$1.86-$1.860%
1995-09-301995-11-14-$1.92-$0.90-113.33%
1995-06-301995-08-15-$1.14-$8.5286.62%
1995-03-311995-05-15-$1.86-$2.6429.55%
1994-12-311995-02-16-$2.16-$2.5816.28%
1994-09-301994-10-25-$2.52-$2.9213.7%
1994-06-301994-08-15-$3.06-$2.58-18.6%

Ligand Pharmaceuticals Incorporated (LGND) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ligand Pharmaceuticals Incorporated (LGND) Chart:

Ligand Pharmaceuticals Incorporated (LGND) News:

Below you will find a list of latest news for Ligand Pharmaceuticals Incorporated (LGND) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ligand Pharmaceuticals Incorporated (LGND) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-17300CALL0 0304.89TRUE00
2024-05-17350CALL0 0175.99TRUE00
2024-05-17400CALL0 0138.15TRUE00
2024-05-17450CALL0 097.07TRUE00
2024-05-17509.25CALL0 095.43TRUE00
2024-05-175517.43CALL0 1180.83TRUE00
2024-05-176012.97CALL0 1954.37TRUE00
2024-05-176515.5CALL0 347.4TRUE00
2024-05-177011.2CALL0 4237.81TRUE00
2024-05-17751.95CALL10 3447.36FALSE1.950
2024-05-17801CALL8 34344.67FALSE-0.2-0.17
2024-05-17852CALL0 2845.18FALSE00
2024-05-17900.95CALL0 450FALSE00
2024-05-17950.95CALL0 40FALSE00
2024-05-171000.2CALL0 570FALSE00
2024-05-171050.36CALL0 100FALSE00
2024-05-171100.25CALL0 392.42FALSE00
2024-05-171150CALL0 00FALSE00
2024-05-171200CALL0 00FALSE00
2024-05-17300PUT0 00FALSE00
2024-05-17350.14PUT0 00FALSE00
2024-05-17400PUT0 00FALSE00
2024-05-17451.55PUT0 100FALSE00
2024-05-17501.13PUT0 660FALSE00
2024-05-17550.15PUT0 1170FALSE00
2024-05-17600.95PUT0 1363.84FALSE00
2024-05-17650.45PUT0 1442.97FALSE00
2024-05-17702.2PUT4 1840.68FALSE2.20
2024-05-17751.55PUT0 238.64TRUE00
2024-05-178010.25PUT0 1123.1TRUE00
2024-05-178511.5PUT0 678.9TRUE00
2024-05-17900PUT0 090TRUE00
2024-05-17950PUT0 0106.48TRUE00
2024-05-171000PUT0 0118.34TRUE00
2024-05-171050PUT0 0129.26TRUE00
2024-05-1711029.8PUT0 0139.39TRUE00
2024-05-171150PUT0 0148.85TRUE00
2024-05-171200PUT0 058.26TRUE00
2024-06-21400CALL0 0110.05TRUE00
2024-06-21450CALL0 090.28TRUE00
2024-06-21500CALL0 075.17TRUE00
2024-06-21550CALL0 063.78TRUE00
2024-06-21600CALL0 055.89TRUE00
2024-06-21650CALL0 045.39TRUE00
2024-06-21700CALL0 045.81TRUE00
2024-06-21750CALL0 044.61FALSE00
2024-06-21800CALL0 040.35FALSE00
2024-06-21850CALL0 044.3FALSE00
2024-06-21900CALL0 052.99FALSE00
2024-06-21950CALL0 075.98FALSE00
2024-06-211000CALL0 00FALSE00
2024-06-211050CALL0 00FALSE00
2024-06-211100CALL0 00FALSE00
2024-06-211150CALL0 00FALSE00
2024-06-211200CALL0 00FALSE00
2024-06-21400PUT0 00FALSE00
2024-06-21450PUT0 00FALSE00
2024-06-21500PUT0 00FALSE00
2024-06-21550PUT0 071.86FALSE00
2024-06-21600PUT0 059.26FALSE00
2024-06-21650PUT0 037.82FALSE00
2024-06-21700PUT0 034.51FALSE00
2024-06-21750PUT0 033.7TRUE00
2024-06-21800PUT0 022.51TRUE00
2024-06-21850PUT0 049.92TRUE00
2024-06-21900PUT0 058.35TRUE00
2024-06-21950PUT0 067.01TRUE00
2024-06-211000PUT0 074.97TRUE00
2024-06-211050PUT0 082.36TRUE00
2024-06-211100PUT0 089.25TRUE00
2024-06-211150PUT0 095.71TRUE00
2024-06-211200PUT0 0101.8TRUE00
2024-08-16350CALL0 0110.08TRUE00
2024-08-16400CALL0 094.01TRUE00
2024-08-16450CALL0 077.98TRUE00
2024-08-16500CALL0 071.83TRUE00
2024-08-16550CALL0 062.55TRUE00
2024-08-16600CALL0 054.77TRUE00
2024-08-16650CALL0 052.17TRUE00
2024-08-167012.5CALL0 1245.33TRUE00
2024-08-16756.25CALL0 847.6FALSE00
2024-08-16808.5CALL0 16644.75FALSE00
2024-08-16852.8CALL0 61844.78FALSE00
2024-08-16903.6CALL0 4040.45FALSE00
2024-08-16952.75CALL0 1150.46FALSE00
2024-08-161001.96CALL0 1148.73FALSE00
2024-08-161050.67CALL0 17756.24FALSE00
2024-08-161100.9CALL0 40FALSE00
2024-08-161150CALL0 00FALSE00
2024-08-161200CALL0 00FALSE00
2024-08-16350PUT0 00FALSE00
2024-08-16400PUT0 00FALSE00
2024-08-16450.59PUT0 10FALSE00
2024-08-16501.1PUT0 370.79FALSE00
2024-08-16550.52PUT0 140.79FALSE00
2024-08-16601.55PUT12 435.93FALSE1.550
2024-08-16652.9PUT5 034.75FALSE2.90
2024-08-16705PUT0 433.25FALSE00
2024-08-16754.05PUT0 234.62TRUE00
2024-08-16806.11PUT0 4625.27TRUE00
2024-08-16850PUT0 037.89TRUE00
2024-08-16900PUT0 036.41TRUE00
2024-08-169510.1PUT0 141.6TRUE00
2024-08-161000PUT0 049.89TRUE00
2024-08-161050PUT0 055.52TRUE00
2024-08-161100PUT0 060.83TRUE00
2024-08-161150PUT0 065.85TRUE00
2024-08-161200PUT0 070.59TRUE00
2024-11-15400CALL0 090.23TRUE00
2024-11-15450CALL0 078.73TRUE00
2024-11-155024.2CALL0 970.05TRUE00
2024-11-15550CALL0 063.45TRUE00
2024-11-15600CALL0 058.15TRUE00
2024-11-15650CALL0 050.78TRUE00
2024-11-157016CALL0 152.34TRUE00
2024-11-15758.74CALL0 5248.01FALSE00
2024-11-15805.9CALL5 7045.86FALSE5.90
2024-11-15858.17CALL0 1046.05FALSE00
2024-11-15902.75CALL0 141.68FALSE00
2024-11-15950CALL0 047.61FALSE00
2024-11-151000CALL0 049.18FALSE00
2024-11-151051.4CALL0 151.32FALSE00
2024-11-151100CALL0 052.05FALSE00
2024-11-151150CALL0 057.57FALSE00
2024-11-151200CALL0 056.6FALSE00
2024-11-15400PUT0 00FALSE00
2024-11-15450PUT0 00FALSE00
2024-11-15501.62PUT0 147.77FALSE00
2024-11-15551.8PUT0 132.91FALSE00
2024-11-15600PUT0 027.13FALSE00
2024-11-15650PUT0 030.7FALSE00
2024-11-15707.6PUT0 430.01FALSE00
2024-11-15750PUT0 027.21TRUE00
2024-11-15800PUT0 018.97TRUE00
2024-11-15850PUT0 033.02TRUE00
2024-11-15900PUT0 027.77TRUE00
2024-11-15950PUT0 027.73TRUE00
2024-11-151000PUT0 028.78TRUE00
2024-11-151050PUT0 034.11TRUE00
2024-11-151100PUT0 039.05TRUE00
2024-11-151150PUT0 043.65TRUE00
2024-11-151200PUT0 047.95TRUE00

Latest LGND Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST46$74.6
Jun 13, 2022 7:59 PM EST21$74.6
Jun 13, 2022 7:59 PM EST10$74.52
Jun 13, 2022 7:59 PM EST2$74.545
Jun 13, 2022 7:59 PM EST4$74.545

Ligand Pharmaceuticals Incorporated (LGND) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000084/0000886163-20-000084-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/886163/000009375120000531/0000093751-20-000531-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/886163/000021545719007313/0000215457-19-007313-index.htm
2020-02-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000076999320000167/0000769993-20-000167-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/886163/000083423720008716/0000834237-20-008716-index.htm
2019-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000005/0000886163-19-000005-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000016/0000886163-19-000016-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000017/0000886163-19-000017-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000018/0000886163-19-000018-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000019/0000886163-19-000019-index.htm
2019-01-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000020/0000886163-19-000020-index.htm
2019-01-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000022/0000886163-19-000022-index.htm
2019-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000024/0000886163-19-000024-index.htm
2019-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000027/0000886163-19-000027-index.htm
2019-02-075Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000029/0000886163-19-000029-index.htm
2019-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000034/0000886163-19-000034-index.htm
2019-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000035/0000886163-19-000035-index.htm
2019-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000036/0000886163-19-000036-index.htm
2019-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000037/0000886163-19-000037-index.htm
2019-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/886163/000088616319000041/0000886163-19-000041-index.htm
2019-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000043/0000886163-19-000043-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000046/0000886163-19-000046-index.htm
2019-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000049/0000886163-19-000049-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000053/0000886163-19-000053-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000054/0000886163-19-000054-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000055/0000886163-19-000055-index.htm
2019-04-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000059/0000886163-19-000059-index.htm
2019-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000063/0000886163-19-000063-index.htm
2019-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/886163/000088616319000065/0000886163-19-000065-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000071/0000886163-19-000071-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/886163/000088616319000077/0000886163-19-000077-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000080/0000886163-19-000080-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000081/0000886163-19-000081-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000083/0000886163-19-000083-index.htm
2019-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000085/0000886163-19-000085-index.htm
2019-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000088/0000886163-19-000088-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000090/0000886163-19-000090-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000093/0000886163-19-000093-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000095/0000886163-19-000095-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000103/0000886163-19-000103-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000104/0000886163-19-000104-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000105/0000886163-19-000105-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000106/0000886163-19-000106-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000107/0000886163-19-000107-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000108/0000886163-19-000108-index.htm
2019-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000111/0000886163-19-000111-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000114/0000886163-19-000114-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000115/0000886163-19-000115-index.htm
2019-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000117/0000886163-19-000117-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000120/0000886163-19-000120-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000121/0000886163-19-000121-index.htm
2019-07-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000126/0000886163-19-000126-index.htm
2019-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000130/0000886163-19-000130-index.htm
2019-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000132/0000886163-19-000132-index.htm
2019-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000134/0000886163-19-000134-index.htm
2019-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000136/0000886163-19-000136-index.htm
2019-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000138/0000886163-19-000138-index.htm
2019-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000140/0000886163-19-000140-index.htm
2019-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000144/0000886163-19-000144-index.htm
2019-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000145/0000886163-19-000145-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/886163/000088616319000156/0000886163-19-000156-index.htm
2019-08-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000157/0000886163-19-000157-index.htm
2019-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000159/0000886163-19-000159-index.htm
2019-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000161/0000886163-19-000161-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000163/0000886163-19-000163-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000165/0000886163-19-000165-index.htm
2019-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000167/0000886163-19-000167-index.htm
2019-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000169/0000886163-19-000169-index.htm
2019-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000174/0000886163-19-000174-index.htm
2019-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000175/0000886163-19-000175-index.htm
2019-09-244/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000177/0000886163-19-000177-index.htm
2019-10-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000184/0000886163-19-000184-index.htm
2019-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000186/0000886163-19-000186-index.htm
2019-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000188/0000886163-19-000188-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616319000191/0000886163-19-000191-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/886163/000088616319000199/0000886163-19-000199-index.htm
2019-11-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000201/0000886163-19-000201-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000206/0000886163-19-000206-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000207/0000886163-19-000207-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000208/0000886163-19-000208-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616319000209/0000886163-19-000209-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616320000002/0000886163-20-000002-index.htm
2020-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616320000007/0000886163-20-000007-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616320000009/0000886163-20-000009-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000014/0000886163-20-000014-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000015/0000886163-20-000015-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000016/0000886163-20-000016-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000017/0000886163-20-000017-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/886163/000088616320000025/0000886163-20-000025-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000027/0000886163-20-000027-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000029/0000886163-20-000029-index.htm
2020-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616320000034/0000886163-20-000034-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616320000037/0000886163-20-000037-index.htm
2020-04-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616320000041/0000886163-20-000041-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000045/0000886163-20-000045-index.htm
2020-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/886163/000088616320000046/0000886163-20-000046-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000050/0000886163-20-000050-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000051/0000886163-20-000051-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000052/0000886163-20-000052-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616320000056/0000886163-20-000056-index.htm
2020-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/886163/000088616320000061/0000886163-20-000061-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000063/0000886163-20-000063-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616320000066/0000886163-20-000066-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000074/0000886163-20-000074-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000075/0000886163-20-000075-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000076/0000886163-20-000076-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000077/0000886163-20-000077-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000078/0000886163-20-000078-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000079/0000886163-20-000079-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000080/0000886163-20-000080-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000083/0000886163-20-000083-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000084/0000886163-20-000084-index.htm
2020-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000087/0000886163-20-000087-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616320000092/0000886163-20-000092-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/886163/000088616320000097/0000886163-20-000097-index.htm
2020-08-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000099/0000886163-20-000099-index.htm
2020-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616320000101/0000886163-20-000101-index.htm
2020-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616320000105/0000886163-20-000105-index.htm
2020-10-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616320000108/0000886163-20-000108-index.htm
2020-10-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616320000110/0000886163-20-000110-index.htm
2020-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616320000112/0000886163-20-000112-index.htm
2020-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000088616320000116/0000886163-20-000116-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000088616320000118/0000886163-20-000118-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/886163/000088616320000122/0000886163-20-000122-index.htm
2020-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000089924320023546/0000899243-20-023546-index.htm
2020-08-284/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000089924320023644/0000899243-20-023644-index.htm
2020-10-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000089924320027886/0000899243-20-027886-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/886163/000091957420001366/0000919574-20-001366-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/886163/000093247119005931/0000932471-19-005931-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/886163/000103738919000060/0001037389-19-000060-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/886163/000103738920000221/0001037389-20-000221-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000110465919034623/0001104659-19-034623-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000110465919043306/0001104659-19-043306-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/886163/000110465920013156/0001104659-20-013156-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/886163/000110465920018004/0001104659-20-018004-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/886163/000110465920073020/0001104659-20-073020-index.htm
2020-10-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/886163/000110465920113287/0001104659-20-113287-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/886163/000114420419007194/0001144204-19-007194-index.htm
2019-04-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/886163/000119312519106750/0001193125-19-106750-index.htm
2019-06-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/886163/000119312519165118/0001193125-19-165118-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000119312519170732/0001193125-19-170732-index.htm
2019-12-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000119312519322605/0001193125-19-322605-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/886163/000119312520033195/0001193125-20-033195-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000119312520215346/0001193125-20-215346-index.htm
2020-08-11SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/886163/000119312520215349/0001193125-20-215349-index.htm
2020-08-11SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/886163/000119312520215352/0001193125-20-215352-index.htm
2020-08-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/886163/000119312520234860/0001193125-20-234860-index.htm
2020-08-31SC TO-TTender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/886163/000119312520235607/0001193125-20-235607-index.htm
2020-09-11SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/886163/000119312520243535/0001193125-20-243535-index.htm
2020-09-16SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/886163/000119312520246636/0001193125-20-246636-index.htm
2020-09-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/886163/000119312520246638/0001193125-20-246638-index.htm
2020-09-30SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/886163/000119312520258665/0001193125-20-258665-index.htm
2020-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/886163/000119312520260585/0001193125-20-260585-index.htm
2020-10-30PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/886163/000119312520282730/0001193125-20-282730-index.htm
2020-01-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/886163/000127417320000002/0001274173-20-000002-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/886163/000156761920003813/0001567619-20-003813-index.htm
2020-06-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/886163/999999999720003624/9999999997-20-003624-index.htm

Ligand Pharmaceuticals Incorporated (LGND) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ligand Pharmaceuticals Incorporated (LGND). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 421%
Institutional Ownership: 14613%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-01-23Matthew E KorenbergEVP,Finance & Strategy and CFOBuy2,230.0010,677.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000016/0000886163-19-000016-index.htm
2019-01-23MATTHEW W FOEHRPresident and COOBuy3,547.00116,934.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000018/0000886163-19-000018-index.htm
2019-01-23MATTHEW W FOEHRPresident and COOBuy3,715.00119,365.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000018/0000886163-19-000018-index.htm
2019-02-11MATTHEW W FOEHRPresident and COOBuy7,472.00125,553.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000036/0000886163-19-000036-index.htm
2019-01-23JOHN L HIGGINSChief Executive OfficerBuy7,256.00126,465.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000017/0000886163-19-000017-index.htm
2019-01-23JOHN L HIGGINSChief Executive OfficerBuy6,390.00129,258.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000017/0000886163-19-000017-index.htm
2019-02-11JOHN L HIGGINSChief Executive OfficerBuy12,809.00138,899.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000035/0000886163-19-000035-index.htm
2019-03-14MATTHEW W FOEHRPresident and COOBuy14,894.009.97148,493.18140,447.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000055/0000886163-19-000055-index.htm
2019-03-13JOHN L HIGGINSChief Executive OfficerBuy2,500.00114.29285,725.00141,399.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000053/0000886163-19-000053-index.htm
2019-06-11MATTHEW W FOEHRPresident and COOBuy1,004.0021.9222,007.68141,451.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000114/0000886163-19-000114-index.htm
2019-08-12MATTHEW W FOEHRPresident and COOBuy1,163.0021.9225,492.96142,614.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000159/0000886163-19-000159-index.htm
2019-10-15Sarah BoyceDirectorBuy1,431.001,431.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000188/0000886163-19-000188-index.htm
2019-09-05MATTHEW W FOEHRPresident and COOBuy1,005.0021.9222,029.60143,619.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000165/0000886163-19-000165-index.htm
2019-05-14JOHN L HIGGINSChief Executive OfficerBuy2,500.00113.50283,750.00143,899.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000081/0000886163-19-000081-index.htm
2019-11-12MATTHEW W FOEHRPresident and COOBuy1,001.0021.9221,941.92144,620.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000201/0000886163-19-000201-index.htm
2019-05-31JOHN L HIGGINSChief Executive OfficerBuy1,000.00108.20108,202.00144,899.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000093/0000886163-19-000093-index.htm
2019-07-31JOHN L HIGGINSChief Executive OfficerBuy1,850.0095.45176,582.50146,749.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000134/0000886163-19-000134-index.htm
2020-02-13MATTHEW W FOEHRPresident and COOBuy496.0021.9210,872.32148,833.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000016/0000886163-20-000016-index.htm
2019-12-20MATTHEW W FOEHRPresident and COOBuy4,458.00149,078.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000207/0000886163-19-000207-index.htm
2019-12-20MATTHEW W FOEHRPresident and COOBuy2,913.00149,781.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000207/0000886163-19-000207-index.htm
2020-02-27MATTHEW W FOEHRPresident and COOSell7,225.00110.00794,750.00153,743.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000027/0000886163-20-000027-index.htm
2019-12-20JOHN L HIGGINSChief Executive OfficerBuy7,668.00154,417.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000206/0000886163-19-000206-index.htm
2020-08-21MATTHEW W FOEHRPresident and COOBuy790.0074.4258,791.80155,413.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000099/0000886163-20-000099-index.htm
2020-08-21MATTHEW W FOEHRPresident and COOSell7,225.00112.88815,540.66155,413.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000099/0000886163-20-000099-index.htm
2020-08-24MATTHEW W FOEHRPresident and COOSell78.00110.898,649.42155,413.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000099/0000886163-20-000099-index.htm
2020-02-27MATTHEW W FOEHRPresident and COOBuy1,706.0021.9237,395.52155,449.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000027/0000886163-20-000027-index.htm
2020-08-24MATTHEW W FOEHRPresident and COOBuy78.0021.921,709.76155,491.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000099/0000886163-20-000099-index.htm
2020-02-13MATTHEW W FOEHRPresident and COOBuy7,396.00156,229.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000016/0000886163-20-000016-index.htm
2020-02-14MATTHEW W FOEHRPresident and COOSell7,225.0095.84692,467.12156,229.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000016/0000886163-20-000016-index.htm
2019-12-20JOHN L HIGGINSChief Executive OfficerBuy5,946.00156,562.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000206/0000886163-19-000206-index.htm
2020-03-13MATTHEW W FOEHRPresident and COOBuy2,000.0021.9243,840.00157,449.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000029/0000886163-20-000029-index.htm
2020-02-27MATTHEW W FOEHRPresident and COOBuy7,225.0014.47104,545.75160,968.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000027/0000886163-20-000027-index.htm
2020-08-21MATTHEW W FOEHRPresident and COOBuy7,225.0014.47104,545.75162,638.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000099/0000886163-20-000099-index.htm
2020-02-14MATTHEW W FOEHRPresident and COOBuy7,225.0014.47104,545.75163,454.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000016/0000886163-20-000016-index.htm
2019-02-11Matthew E KorenbergEVP,Finance & Strategy and CFOBuy6,404.0016,469.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000037/0000886163-19-000037-index.htm
2019-09-03Matthew E KorenbergEVP,Finance & Strategy and CFOBuy500.0086.1843,090.7517,151.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000161/0000886163-19-000161-index.htm
2019-12-20Matthew E KorenbergEVP,Finance & Strategy and CFOBuy2,674.0019,825.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000209/0000886163-19-000209-index.htm
2020-07-07JOHN L HIGGINSChief Executive OfficerBuy1,165.0085.7999,945.35201,421.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000087/0000886163-20-000087-index.htm
2020-02-13JOHN L HIGGINSChief Executive OfficerBuy48,125.009.96479,325.00201,739.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000017/0000886163-20-000017-index.htm
2020-07-07JOHN L HIGGINSChief Executive OfficerBuy1,777.0056.2699,974.02203,198.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000087/0000886163-20-000087-index.htm
2020-07-07JOHN L HIGGINSChief Executive OfficerBuy1,373.0074.42102,178.66204,571.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000087/0000886163-20-000087-index.htm
2019-12-20Matthew E KorenbergEVP,Finance & Strategy and CFOBuy2,305.0020,995.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000209/0000886163-19-000209-index.htm
2020-02-13JOHN L HIGGINSChief Executive OfficerBuy13,559.00210,289.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000017/0000886163-20-000017-index.htm
2019-06-06JOHN L LAMATTINADirectorBuy835.0022,284.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000104/0000886163-19-000104-index.htm
2019-06-06Nancy Ryan GrayDirectorBuy835.002,241.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000106/0000886163-19-000106-index.htm
2020-06-10Sarah BoyceDirectorBuy831.002,262.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000079/0000886163-20-000079-index.htm
2019-07-31Stephen L SabbaDirectorSell4,091.0094.45386,394.9523,600.00https://www.sec.gov/Archives/edgar/data/886163/000110465919043306/0001104659-19-043306-index.htm
2020-06-10Stephen L SabbaDirectorBuy831.0024,431.00https://www.sec.gov/Archives/edgar/data/886163/000110465920073020/0001104659-20-073020-index.htm
2020-06-10JOHN L LAMATTINADirectorBuy831.0024,768.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000075/0000886163-20-000075-index.htm
2019-08-01JOHN L LAMATTINADirectorBuy2,500.0032.3080,750.0024,784.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000138/0000886163-19-000138-index.htm
2019-06-06Sunil PatelDirectorBuy835.0025,359.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000103/0000886163-19-000103-index.htm
2019-05-14JOHN W KOZARICHDirectorSell2,500.00112.92282,300.0025,542.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000080/0000886163-19-000080-index.htm
2019-08-02Sunil PatelDirectorBuy1,000.0095.9895,980.0026,359.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000136/0000886163-19-000136-index.htm
2019-06-06JOHN W KOZARICHDirectorBuy835.0026,377.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000105/0000886163-19-000105-index.htm
2020-02-13Matthew E KorenbergEVP,Finance & Strategy and CFOBuy6,848.0026,864.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000014/0000886163-20-000014-index.htm
2020-06-10Sunil PatelDirectorBuy831.0027,190.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000074/0000886163-20-000074-index.htm
2020-06-10JOHN W KOZARICHDirectorBuy831.0027,208.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000076/0000886163-20-000076-index.htm
2019-06-06Stephen L SabbaDirectorBuy835.0027,691.00https://www.sec.gov/Archives/edgar/data/886163/000110465919034623/0001104659-19-034623-index.htm
2019-05-14JOHN W KOZARICHDirectorBuy2,500.0017.8844,700.0028,042.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000080/0000886163-19-000080-index.htm
2020-11-02Sunil PatelDirectorBuy1,000.0082.5282,520.0028,190.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000118/0000886163-20-000118-index.htm
2020-06-10Nancy Ryan GrayDirectorBuy831.003,072.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000077/0000886163-20-000077-index.htm
2019-01-10Charles S BerkmanSVP, Gen. Counsel & SecretaryBuy244.0021.925,348.4837,307.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000005/0000886163-19-000005-index.htm
2019-01-10Charles S BerkmanSVP, Gen. Counsel & SecretaryBuy1,931.0074.42143,705.0239,238.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000005/0000886163-19-000005-index.htm
2019-01-10Charles S BerkmanSVP, Gen. Counsel & SecretaryBuy675.0056.2637,975.5039,913.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000005/0000886163-19-000005-index.htm
2020-06-04Charles S BerkmanSVP, Gen. Counsel & SecretarySell11,146.00118.591,321,775.1640,877.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000063/0000886163-20-000063-index.htm
2019-01-23Charles S BerkmanSVP, Gen. Counsel & SecretaryBuy1,370.0041,283.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000019/0000886163-19-000019-index.htm
2019-01-23Charles S BerkmanSVP, Gen. Counsel & SecretaryBuy1,412.0042,695.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000019/0000886163-19-000019-index.htm
2019-02-11Charles S BerkmanSVP, Gen. Counsel & SecretaryBuy3,202.0045,897.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000034/0000886163-19-000034-index.htm
2019-08-05Charles S BerkmanSVP, Gen. Counsel & SecretaryBuy669.0056.2637,637.9446,748.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000144/0000886163-19-000144-index.htm
2019-08-05Charles S BerkmanSVP, Gen. Counsel & SecretaryBuy424.0085.7936,374.9647,172.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000144/0000886163-19-000144-index.htm
2019-06-06Todd C DavisDirectorBuy835.0048,474.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000107/0000886163-19-000107-index.htm
2019-12-20Charles S BerkmanSVP, Gen. Counsel & SecretaryBuy1,693.0048,865.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000208/0000886163-19-000208-index.htm
2019-08-02Todd C DavisDirectorBuy1,000.0093.5993,594.4049,474.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000140/0000886163-19-000140-index.htm
2019-12-20Charles S BerkmanSVP, Gen. Counsel & SecretaryBuy1,335.0049,615.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000208/0000886163-19-000208-index.htm
2020-06-10Todd C DavisDirectorBuy831.0050,305.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000078/0000886163-20-000078-index.htm
2019-03-13Jason AryehDirectorBuy202.00112.5122,727.0251,594.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000054/0000886163-19-000054-index.htm
2020-02-13Charles S BerkmanSVP, Gen. Counsel & SecretaryBuy3,835.0052,904.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000015/0000886163-20-000015-index.htm
2020-08-26LIGAND PHARMACEUTICALS INC10% Share HolderSell94,488.008.11766,108.705,819,383.00https://www.sec.gov/Archives/edgar/data/886163/000089924320023546/0000899243-20-023546-index.htm
2019-05-14Jason AryehDirectorBuy250.00112.5128,127.5059,368.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000083/0000886163-19-000083-index.htm
2019-05-20Jason AryehDirectorBuy250.00112.0128,002.5059,618.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000085/0000886163-19-000085-index.htm
2020-08-25LIGAND PHARMACEUTICALS INC10% Share HolderSell70,000.008.02561,575.005,968,083.00https://www.sec.gov/Archives/edgar/data/886163/000089924320023546/0000899243-20-023546-index.htm
2019-05-29Jason AryehDirectorBuy250.00111.0127,752.5059,868.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000090/0000886163-19-000090-index.htm
2019-05-30Jason AryehDirectorBuy250.00110.0127,502.5060,118.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000090/0000886163-19-000090-index.htm
2019-05-31Jason AryehDirectorBuy500.00108.5154,255.0060,618.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000090/0000886163-19-000090-index.htm
2019-06-06Jason AryehDirectorBuy835.0061,453.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000108/0000886163-19-000108-index.htm
2019-06-11Jason AryehDirectorBuy250.00107.0126,752.5061,703.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000115/0000886163-19-000115-index.htm
2019-07-29Jason AryehDirectorBuy250.00106.0126,502.5061,953.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000132/0000886163-19-000132-index.htm
2019-07-30Jason AryehDirectorBuy3,000.00100.22300,662.7064,953.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000132/0000886163-19-000132-index.htm
2019-07-31Jason AryehDirectorBuy754.0093.0070,121.5565,707.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000132/0000886163-19-000132-index.htm
2019-08-05Jason AryehDirectorBuy746.0090.0167,145.9766,453.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000145/0000886163-19-000145-index.htm
2019-09-03Jason AryehDirectorBuy750.0087.0165,257.5067,203.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000163/0000886163-19-000163-index.htm
2020-06-10Jason AryehDirectorBuy831.0068,034.00https://www.sec.gov/Archives/edgar/data/886163/000088616320000080/0000886163-20-000080-index.htm
2019-01-23Matthew E KorenbergEVP,Finance & Strategy and CFOBuy2,418.009,160.00https://www.sec.gov/Archives/edgar/data/886163/000088616319000016/0000886163-19-000016-index.htm